Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis

Starting soon · Not applicable

Conditions studied: Liver Cirrhosis

In brief

the study includes patients with liver cirrhosis irrespective of the stage excluding people with active tumor or other major health issue endangering life, the protocol includes the use of autologous bone marrow derived mononuclear cells harvested from the same patient under local anesthesia ,followed by cell concentration and viability testing , then final product is combined with small volume of 2 cc of Wharton gel exosomes 20 billion per to be administered intravenously.

Key facts

Study ID

NCT07374185

Run by

Global Stem Cell Center, Baghdad

People needed

10

Starts

2026-02-20

Expected to finish

2026-12-20

Last updated by the study team

2026-01-28

Who can join

Age: any, up to 80. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• active malignancy.
• severe sepsis.
• pregnancy. -

Where it is running

• Capital Private Hospital Alrabee Street — Baghdad, Iraq, Iraq

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.